Differential effects of slow rewarming after cerebral hypothermia on white matter recovery after global cerebral ischemia in near-term fetal sheep.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 07 2019
Historique:
received: 19 03 2019
accepted: 27 06 2019
entrez: 14 7 2019
pubmed: 14 7 2019
medline: 15 12 2020
Statut: epublish

Résumé

It is widely believed that rewarming slowly after therapeutic hypothermia for hypoxic-ischemic (HI) encephalopathy can improve outcomes, but its impact on white matter injury after HI is unclear. Fetal sheep (0.85 gestation) received 30 min ischemia-normothermia (n = 8), or hypothermia from 3-48 h with rapid spontaneous rewarming over 1 h (ischemia-48 h hypothermia, n = 8), or 48 h with slow rewarming over 24 h (ischemia-slow rewarming, n = 7) or 72 h with rapid rewarming (ischemia-72 h hypothermia, n = 8). Ischemia was associated with loss of total and mature oligodendrocytes and reduced area fraction of myelin basic protein (MBP) and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase; immature/mature oligodendrocytes) and increased microglia and astrocytes. Total numbers of oligodendrocytes were increased by all hypothermia protocols but only ischemia-72 h hypothermia attenuated loss of mature oligodendrocytes. All hypothermia protocols similarly increased the area fraction of MBP, whereas there was only an intermediate effect on the area fraction of CNPase. Microglia were suppressed by all hypothermia protocols, with the greatest reduction after ischemia-72 h hypothermia, and an intermediate effect after ischemia-slow rewarming. By contrast, induction of astrocytes was significantly reduced only after ischemia-slow rewarming. In conclusion, slow rewarming after hypothermia did not improve oligodendrocyte survival or myelination or suppression of microgliosis compared to fast rewarming, but modestly reduced astrocytosis.

Identifiants

pubmed: 31300687
doi: 10.1038/s41598-019-46505-0
pii: 10.1038/s41598-019-46505-0
pmc: PMC6626025
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10142

Références

Pediatrics. 1998 Nov;102(5):1098-106
pubmed: 9794940
J Cereb Blood Flow Metab. 2018 Jun;38(6):1047-1059
pubmed: 28504050
Sci Rep. 2016 Apr 28;6:25178
pubmed: 27121655
Curr Drug Targets. 2013 Jan 1;14(1):36-46
pubmed: 23170795
J Pediatr. 2012 Nov;161(5):799-807
pubmed: 22682614
Lancet. 2005 Feb 19-25;365(9460):663-70
pubmed: 15721471
J Cereb Blood Flow Metab. 2015 May;35(5):781-93
pubmed: 25564240
Neuroscience. 2016 Mar 1;316:296-310
pubmed: 26739327
J Cereb Blood Flow Metab. 2019 Nov;39(11):2246-2257
pubmed: 30092709
Kobe J Med Sci. 2003;49(3-4):83-91
pubmed: 14970751
J Cereb Blood Flow Metab. 1999 Jul;19(7):742-9
pubmed: 10413028
J Cereb Blood Flow Metab. 2004 Aug;24(8):877-86
pubmed: 15362718
J Clin Invest. 1997 Jan 15;99(2):248-56
pubmed: 9005993
J Cereb Blood Flow Metab. 2011 Apr;31(4):991-3
pubmed: 21206507
J Child Neurol. 2019 Sep;34(10):556-566
pubmed: 31070085
Neurology. 2011 Jun 14;76(24):2055-61
pubmed: 21670434
BMJ. 2010 Feb 09;340:c363
pubmed: 20144981
J Physiol. 2018 Dec;596(23):5641-5654
pubmed: 29660115
N Engl J Med. 2005 Oct 13;353(15):1574-84
pubmed: 16221780
Pediatr Res. 2010 Sep;68(3):205-9
pubmed: 20520585
Pediatrics. 2000 Jul;106(1 Pt 1):92-9
pubmed: 10878155
Pediatrics. 2004 Nov;114(5):1369
pubmed: 15520131
Glia. 2010 Jan 15;58(2):181-94
pubmed: 19606499
J Cereb Blood Flow Metab. 2015 May;35(5):751-8
pubmed: 25605291
Ann Neurol. 1992 Jan;31(1):14-21
pubmed: 1543346
Neuroimage Clin. 2017 Jun 10;15:572-580
pubmed: 28924555
Brain Res. 2010 Mar 10;1319:164-74
pubmed: 20079338
J Pediatr. 2015 Nov;167(5):987-93.e3
pubmed: 26387012
J Pediatr. 2005 Apr;146(4):453-60
pubmed: 15812446
Ann Neurol. 2012 Jan;71(1):121-32
pubmed: 22275258
Stroke. 1996 May;27(5):913-8
pubmed: 8623113

Auteurs

V Draghi (V)

Department of Physiology, The University of Auckland, Auckland, New Zealand.

G Wassink (G)

Department of Physiology, The University of Auckland, Auckland, New Zealand.

K Q Zhou (KQ)

Department of Physiology, The University of Auckland, Auckland, New Zealand.

L Bennet (L)

Department of Physiology, The University of Auckland, Auckland, New Zealand.

A J Gunn (AJ)

Department of Physiology, The University of Auckland, Auckland, New Zealand. aj.gunn@auckland.ac.nz.

J O Davidson (JO)

Department of Physiology, The University of Auckland, Auckland, New Zealand.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH